Pharmacoeconomic analysis by the cost-minimization method of fluconazole drugs recommended for use in candidiosis
Candidiasis is a group of fungal diseases of the skin, mucous membranes and internal organs caused by fungi of the genus Candida. Candidiasis treatment is mainly carried out with antifungal agents for systemic use. Fluconazole preparations, which have proven clinical efficacy and safety, and are als...
Main Authors: | O. V. Tkachova, L. V. Iakovlieva, T. I. Sheptak |
---|---|
Format: | Article |
Language: | Ukrainian |
Published: |
The State Expert Center of the Ministry of Health of Ukraine
2020-07-01
|
Series: | Фармацевтичний журнал |
Subjects: | |
Online Access: | https://pharmj.org.ua/index.php/journal/article/view/883/828 |
Similar Items
-
Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
by: Zahra Vahedpoor, et al.
Published: (2022-04-01) -
Evaluación de la susceptibilidad de especies de Candida al fluconazol por el método de difusión de disco.
by: Catalina de Bedout, et al.
Published: (2003-03-01) -
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01) -
Single and multiple dose Fluconazole in the treatment of candidia vulvovaginitis: a prospective comparative study
by: Ashrafinia M, et al.
Published: (2007-09-01) -
Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action
by: C.I.S. Medeiros, et al.
Published: (2022-08-01)